CVS (CVS) adds Lilly’s (LLY) Zepbound to its preferred drug list in a reversal of prior stance, Bloomberg reports
#CVS CAREMARK CORP#CVS.US#ELI LILLY & CO#LLY.US#EQUITIES#EU SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#CVS HEALTH CORP#CVS#ELI LILLY AND CO#LLY#US EQUITIES